Sunniva
Dr. Anthony (Tony) Holler is the former CEO and co-founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.
This person is not in any offices
Sunniva
Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world's two largest cannabis markets - Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed glasshouses,…